1,2-distearoylphosphatidylethanolamine has been researched along with g(m1) ganglioside in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, TM; Hansen, C | 1 |
| Kosugi, T; Namba, Y; Okada, S; Oku, N; Tokudome, Y; Tsukada, H | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and g(m1) ganglioside
| Article | Year |
|---|---|
Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
Topics: Animals; Cholesterol; Drug Carriers; Female; G(M1) Ganglioside; Half-Life; Liposomes; Mice; Monocytes; Phagocytes; Phosphatidylcholines; Phosphatidylethanolamines; Software; Sphingomyelins | 1991 |
In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cholesterol; Deoxyglucose; Drug Carriers; Fluorine Radioisotopes; Fluorodeoxyglucose F18; G(M1) Ganglioside; Glucuronates; Isotope Labeling; Liposomes; Male; Mice; Mice, Inbred BALB C; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Sarcoma, Experimental; Tomography, Emission-Computed | 1996 |